Seizert Capital Partners’s CRH Medical Corporation CRHM Stock Holding History

Seizert Capital Partners’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-81,193	Closed	-$189K	–	210
2020 Q4	$189K	Hold	81,193	–	–	0.01%	186
2020 Q3	$176K	Sell	81,193 -19,705	-20%	-$46K	0.01%	179
2020 Q2	$209K	Buy	+100,898	New	+$204K	0.01%	185
2020 Q1	–	Sell	-150,115	Closed	-$521K	–	241
2019 Q4	$521K	Sell	150,115 -7,822	-5%	-$24.7K	0.03%	152
2019 Q3	$486K	Hold	157,937	–	–	0.02%	147
2019 Q2	$479K	Sell	157,937 -12,905	-8%	-$36.9K	0.02%	154
2019 Q1	$454K	Hold	170,842	–	–	0.02%	166
2018 Q4	$521K	Hold	170,842	–	–	0.02%	148
2018 Q3	$675K	Hold	170,842	–	–	0.02%	146
2018 Q2	$436K	Hold	170,842	–	–	0.02%	167
2018 Q1	$436K	Sell	170,842 -43,775	-20%	-$123K	0.02%	167
2017 Q4	$569K	Buy	+214,617	New	+$479K	0.02%	139

Other funds holding CRHM

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

MRCM

Mill Road Capital Management Greenwich, Connecticut $191M AUM 56.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Seizert Capital Partners's CRHM Position: Q1 2021 in Review

Seizert Capital Partners sold out of CRH Medical Corporation (CRHM) in Q1 2021, closing a stake of 81,193 shares — an estimated $189K sold.

Seizert Capital Partners first reported a position in CRHM in Q4 2017 and held it in 12 quarters. The position peaked at $675K in Q3 2018. 59 funds tracked by Wall St. Rank hold CRHM as of Q1 2021.

Seizert Capital Partners reported no remaining CRH Medical Corporation position as of Q1 2021 after selling out during the quarter.
Seizert Capital Partners sold 81,193 CRH Medical Corporation shares in Q1 2021, an estimated $189K.
Seizert Capital Partners first reported a position in CRH Medical Corporation in Q4 2017 and held it in 12 quarters.
Seizert Capital Partners's CRH Medical Corporation position peaked at $675K in Q3 2018.
59 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q1 2021.

Based on Seizert Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.